Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Martine Hoogendoorn (Rotterdam, Netherlands), Martine Hoogendoorn, Talitha Feenstra, Yumi Asukai, Andrew Briggs, Ryan Hansen, Reiner Leidl, Nancy Risebrough, Yevgeniy Samyshkin, Margarethe Wacker, Maureen Rutten-van Mölken. External validation of exacerbation and mortality outcomes of health economic decision models for COPD. Eur Respir J 2016; 48: Suppl. 60, 3120

Member's Comments

No comment yet.

Related content which might interest you: The clinical and economic impact of the combined interventions of telehealth, specialist respiratory nursing care and health coaching interventions for COPD admissions within an urban setting Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Cost and effectiveness of 2 years integrated care intervention in COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Understanding inequalities in COPD prevention and care policies across Europe Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 The impact of implementing a COPD care bundle on the delivery of care to patients admitted with an acute exacerbation of COPD Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Profiling hospital performance to monitor the quality of care: the case of COPD Source: Eur Respir J 2010; 35: 1031-1038 Year: 2010 Methodological issues in evaluating measures of health as outcomes for COPD Source: Eur Respir J 2003; 21: 13S-18S Year: 2003 Does registration of performance indicators improve health outcomes in COPD? Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 The impact of a primary care based educational programme in the management of COPD and asthma on the acute sector Source: Eur Respir J 2004; 24: Suppl. 48, 86s Year: 2004 A competence framework to support the development of the workforce to deliver improved outcomes for patients with COPD and asthma Source: Annual Congress 2012 - Professional development and advanced practice roles in respiratory nursing Year: 2012 Predictive value of annual costs on 3-year mortality in COPD Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 A public health approach to COPD Source: Eur Respir J 2004; 24: Suppl. 48, 65s Year: 2004 Health outcomes assessment and economic evaluation in COPD: challenges and opportunities Source: Eur Respir J 2003; 21: 1S-3S Year: 2003 Using the DOSE index to predict changes in health status and hospitalisation of COPD patients Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Does NICE COPD audit tools affect management of COPD? Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Costs and benefits of pulmonary rehabilitation to COPD patients apply in primary health care Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Optimism, exacerbations and health outcomes of pulmonary rehabilitation in patients with COPD Source: Virtual Congress 2021 – Psychological and behavioural issues in respiratory care Year: 2021 Validity and interpretation of mortality, health service and survey data on COPD and asthma in England Source: Eur Respir J 2003; 21: 279-286 Year: 2003 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Severe COPD: assessment of impairment, quality of life and burden on health care resources Source: Annual Congress 2004 - PG4 - Management of end-stage patients with COPD Year: 2004